128 related articles for article (PubMed ID: 23421078)
1. [Crystal and molecular structure of cytisine salts].
Niedźwiecka J; Przybył AK; Kubicki M
Przegl Lek; 2012; 69(10):998-1003. PubMed ID: 23421078
[TBL] [Abstract][Full Text] [Related]
2. In pursuit of alpha4beta2 nicotinic receptor partial agonists for smoking cessation: carbon analogs of (-)-cytisine.
Coe JW; Vetelino MG; Bashore CG; Wirtz MC; Brooks PR; Arnold EP; Lebel LA; Fox CB; Sands SB; Davis TI; Schulz DW; Rollema H; Tingley FD; O'Neill BT
Bioorg Med Chem Lett; 2005 Jun; 15(12):2974-9. PubMed ID: 15908213
[TBL] [Abstract][Full Text] [Related]
3. In silico characterization of cytisinoids docked into an acetylcholine binding protein.
Abin-Carriquiry JA; Zunini MP; Cassels BK; Wonnacott S; Dajas F
Bioorg Med Chem Lett; 2010 Jun; 20(12):3683-7. PubMed ID: 20493692
[TBL] [Abstract][Full Text] [Related]
4. Cytisine: a natural product lead for the development of drugs acting at nicotinic acetylcholine receptors.
Pérez EG; Méndez-Gálvez C; Cassels BK
Nat Prod Rep; 2012 May; 29(5):555-67. PubMed ID: 22367109
[TBL] [Abstract][Full Text] [Related]
5. Chemical medicine: novel 10-substituted cytisine derivatives with increased selectivity for alpha4beta2 nicotinic acetylcholine receptors.
Kozikowski AP; Chellappan SK; Xiao Y; Bajjuri KM; Yuan H; Kellar KJ; Petukhov PA
ChemMedChem; 2007 Aug; 2(8):1157-61. PubMed ID: 17530728
[No Abstract] [Full Text] [Related]
6. Cytisine-like alkaloids from Ormosia hosiei Hemsl. & E.H. Wilson.
Pouny I; Batut M; Vendier L; David B; Yi S; Sautel F; Arimondo PB; Massiot G
Phytochemistry; 2014 Nov; 107():97-101. PubMed ID: 25172516
[TBL] [Abstract][Full Text] [Related]
7. Deconstructing cytisine: The syntheses of (+/-)-cyfusine and (+/-)-cyclopropylcyfusine, fused ring analogs of cytisine.
Yohannes D; Procko K; Lebel LA; Fox CB; O'Neill BT
Bioorg Med Chem Lett; 2008 Apr; 18(7):2316-9. PubMed ID: 18356044
[TBL] [Abstract][Full Text] [Related]
8. C3-halogenation of cytisine generates potent and efficacious nicotinic receptor agonists.
Abin-Carriquiry JA; Voutilainen MH; Barik J; Cassels BK; Iturriaga-Vásquez P; Bermudez I; Durand C; Dajas F; Wonnacott S
Eur J Pharmacol; 2006 Apr; 536(1-2):1-11. PubMed ID: 16563372
[TBL] [Abstract][Full Text] [Related]
9. Probing Binding Interactions of Cytisine Derivatives to the α4β2 Nicotinic Acetylcholine Receptor.
Blom AEM; Campello HR; Lester HA; Gallagher T; Dougherty DA
J Am Chem Soc; 2019 Oct; 141(40):15840-15849. PubMed ID: 31518499
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and pharmacological evaluation of novel 9- and 10-substituted cytisine derivatives. Nicotinic ligands of enhanced subtype selectivity.
Chellappan SK; Xiao Y; Tueckmantel W; Kellar KJ; Kozikowski AP
J Med Chem; 2006 May; 49(9):2673-6. PubMed ID: 16640326
[TBL] [Abstract][Full Text] [Related]
11. Core modification of cytisine: a modular synthesis.
Hirschhäuser C; Haseler CA; Gallagher T
Angew Chem Int Ed Engl; 2011 May; 50(22):5162-5. PubMed ID: 21520366
[No Abstract] [Full Text] [Related]
12. alpha4beta2 nicotinic receptors with high and low acetylcholine sensitivity: pharmacology, stoichiometry, and sensitivity to long-term exposure to nicotine.
Moroni M; Zwart R; Sher E; Cassels BK; Bermudez I
Mol Pharmacol; 2006 Aug; 70(2):755-68. PubMed ID: 16720757
[TBL] [Abstract][Full Text] [Related]
13. Cytisine and cytisine derivatives. More than smoking cessation aids.
Gotti C; Clementi F
Pharmacol Res; 2021 Aug; 170():105700. PubMed ID: 34087351
[TBL] [Abstract][Full Text] [Related]
14. Cytisine basicity, solvation, logP, and logD theoretical determination as tool for bioavailability prediction.
Pieńko T; Grudzień M; Taciak PP; Mazurek AP
J Mol Graph Model; 2016 Jan; 63():15-21. PubMed ID: 26609940
[TBL] [Abstract][Full Text] [Related]
15. Identification of 9-fluoro substituted (-)-cytisine derivatives as ligands with high affinity for nicotinic receptors.
Houllier N; Gopisetti J; Lestage P; Lasne MC; Rouden J
Bioorg Med Chem Lett; 2010 Nov; 20(22):6667-70. PubMed ID: 20880707
[TBL] [Abstract][Full Text] [Related]
16. Cytisine for smoking cessation: a research agenda.
Etter JF; Lukas RJ; Benowitz NL; West R; Dresler CM
Drug Alcohol Depend; 2008 Jan; 92(1-3):3-8. PubMed ID: 17825502
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular and behavioral responses to nicotinic agents administered intrathecally.
Khan IM; Taylor P; Yaksh TL
J Pharmacol Exp Ther; 1994 Jul; 270(1):150-8. PubMed ID: 8035311
[TBL] [Abstract][Full Text] [Related]
18. [3H]cytisine binding to nicotinic cholinergic receptors in brain.
Pabreza LA; Dhawan S; Kellar KJ
Mol Pharmacol; 1991 Jan; 39(1):9-12. PubMed ID: 1987453
[TBL] [Abstract][Full Text] [Related]
19. (-)-Cytisine and derivatives: synthesis, reactivity, and applications.
Rouden J; Lasne MC; Blanchet J; Baudoux J
Chem Rev; 2014 Jan; 114(1):712-78. PubMed ID: 24117010
[No Abstract] [Full Text] [Related]
20. A short synthesis of (+/-)-cytisine.
Botuha C; Galley CM; Gallagher T
Org Biomol Chem; 2004 Jul; 2(13):1825-6. PubMed ID: 15227532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
